Direct Versus Indirect Effect of Amino Acids on Hepatokines

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Non-Alcoholic Fatty Liver DiseaseObesity
Interventions
OTHER

Evaluating the acute effect of an amino acid infusion with and without a concomitant infusion of the somatostatin analogue octreotide to eliminate endogenous production of glucagon

"The experimental days consist of four study days:~1. Assessment of liver fat and visceral fat by magnetic resonance imaging (MRI; 6-point Dixon) (study day A)~2. Somatostatin infusion (4 hours) plus amino acid infusion (45 minutes) (study day B)~3. Saline infusion (4 hours) plus amino acid infusion (45 minutes) (study day C)~4. Somatostatin infusion (4 hours) plus saline infusion (45 minutes) (study day D)~The subjects will participate in the experimental days (study day B to D) in randomized order on three different days. For study day B to D, at timepoint t = -75, subjects will receive either; a 240-minute intravenous infusion of a somatostatin analogue (at 200 ng/kg/min (infusion rate will not exceed 1000 µg/hour) or saline. After 75 minutes (timepoint t = 0), the subjects will receive a 45-minute intravenous infusion of amino acids or saline at 3.885 ml/kg/hour.~In total, blood will be sampled 11 times over a period of 6 hours and 15 minutes."

Trial Locations (1)

Unknown

Bispebjerg University Hospital, Copenhagen

All Listed Sponsors
collaborator

Bispebjerg Hospital

OTHER

lead

University of Copenhagen

OTHER

NCT06240039 - Direct Versus Indirect Effect of Amino Acids on Hepatokines | Biotech Hunter | Biotech Hunter